Drugs Index
Medical Conditions:
- Medical Conditions G
- Medical Conditions I
- Medical Conditions P
- Medical Conditions C
- Medical Conditions N
- Medical Conditions T
- Medical Conditions E
- Medical Conditions D
- Medical Conditions F
- Medical Conditions H
- Medical Conditions M
- Medical Conditions B
- Medical Conditions U
- Medical Conditions O
- Medical Conditions S
- Medical Conditions A
- Medical Conditions R
- Medical Conditions L
- Medical Conditions W
- Medical Conditions V
- Medical Conditions K
- Medical Conditions J
- Medical Conditions X
Drug Classes
- Drug Classes A
- Drug Classes M
- Drug Classes H
- Drug Classes C
- Drug Classes B
- Drug Classes U
- Drug Classes T
- Drug Classes O
- Drug Classes I
- Drug Classes N
- Drug Classes V
- Drug Classes E
- Drug Classes G
- Drug Classes P
- Drug Classes L
- Drug Classes Q
- Drug Classes F
- Drug Classes S
- Drug Classes D
- Drug Classes R
- Drug Classes 5
- Drug Classes K
Drugs Information:
Drugs List
1. Name Of The Medicinal Product
Glytrin, 400 micrograms per metered dose, Sublingual Spray
2. Qualitative And Quantitative Composition
Active Ingredient:
Glyceryl Trinitrate: 400 micrograms per metered dose
This product contains small amounts of ethanol (alcohol) less than 100mg per spray.
For full list of excipients, see Section 6.1
3. Pharmaceutical Form
Metered dose oromucosal (sublingual) spray solution.
Small aerosol canister
4. Clinical Particulars
4.1 Therapeutic Indications
Treatment of acute angina pectoris
Prevention of inducible angina (e.g. physical effort, emotional stress, exposure to cold)
Route of Administration
Oromucosal (Sublingual)
4.2 Posology And Method Of Administration
Oromucosal Dosage
Adults including the elderly
At the onset of an attack, one or two metered doses (400 to 800 micrograms glyceryl trinitrate) to be sprayed under the tongue for the relief of anginal pain while breath is held. No more than three doses are recommended at any one time.
For the prevention of inducible angina (e.g. physical effort, emotional stress, exposure to cold), one or two 400 microgram metered doses sprayed under the tongue within 2 – 3 minutes of the event starting.
Children
Glytrin is not recommended for children
Administration
During application the patient should rest, ideally in the sitting position. The canister should be held vertically with the valve head uppermost and the spray orifice a
1. Name Of The Medicinal Product
Gentisone HC Ear Drops.
2. Qualitative And Quantitative Composition
Gentisone HC ear drops is a sterile aqueous suspension in 10ml dropper bottles containing gentamicin sulphate, equivalent to 0.3% w/v gentamicin base and 1.0% w/v hydrocortisone acetate.
3. Pharmaceutical Form
Sterile aqueous suspension.
4. Clinical Particulars
4.1 Therapeutic Indications
Gentisone HC ear drops are indicated:
1. For the treatment of eczema and infection of the outer ear (otitis externa).
2. For prophylaxis against otitis externa following trauma.
3. For post-operative local use in surgery to infected mastoid cavities.
4.2 Posology And Method Of Administration
For all ages
The area should be cleaned and 2 - 4 drops instilled in the affected ear three to four times a day and at night. Alternatively, wicks medicated with Gentisone HC drops may be placed in the external ear or mastoid cavity.
4.3 Contraindications
Hypersensitivity to gentamicin or to any of the ingredients. Known or suspected perforation of the ear drum is a contra-indication to use in otitis externa only.
4.4 Special Warnings And Precautions For Use
Long-term continuous topical therapy should be avoided. Prolonged use may lead to skin sensitisation and the emergence of resistant organisms. Cross sensitivity with other aminoglycoside antibiotics may occur.
In severe infections, topical use of Gentisone HC should be supplemented with appropriate systemic antibiotic treatment.
The condition of the ear drum must always be checked before this medicinal prod
1. Name Of The Medicinal Product
Gaviscon Double Action Liquid.
2. Qualitative And Quantitative Composition
Each 10 ml dose contains sodium alginate 500 mg, sodium bicarbonate 213 mg and calcium carbonate 325 mg.
For excipients, see Section 6.1.
3. Pharmaceutical Form
Oral suspension.
4. Clinical Particulars
4.1 Therapeutic Indications
Treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn and indigestion, for example following meals or during pregnancy, and for symptoms of excess stomach acid (hyperacidity).
4.2 Posology And Method Of Administration
For oral administration.
Adults and children 12 years and over: 10-20 ml after meals and at bedtime, up to four times per day.
Children under 12 years: Should be given only on medical advice.
Elderly: No dose modifications necessary for this age group.
4.3 Contraindications
Hypersensitivity to any of the ingredients, including the esters of hydroxybenzoates (parabens).
4.4 Special Warnings And Precautions For Use
Each 20 ml dose has a sodium content of 254.5 mg (11.06 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment.
Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.
Treatment of children younger than 12 years of age is not generally recommended, except on medical advice.
If symptoms do not improve after seven days, the clinical situation shou
Gemcitabine 200mg powder for solution for infusion
Gemcitabine 1g powder for solution for infusion
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.
In this leaflet:
- 1. What Gemcitabine powder is and what it is used for
- 2. Before you use
- 3. How to use
- 4. Possible side effects
- 5. How to store
- 6. Further information
What Gemcitabine Powder Is And What It Is Used For
Gemcitabine powder belongs to a group of medicines called “cytotoxics”. These medicines kill dividing cells, including cancer cells.
Gemcitabine powder may be given alone or in combination with other anti-cancer medicines, depending on the type of cancer.
Gemcitabine powder is used in the treatment of the following types of cancer:
- non-small cell lung cancer (NSCLC), alone or together with cisplatin
- pancreatic cancer.
- breast cancer, together with paclitaxel.
- ovarian cancer, together with carboplatin.
- bladder cancer, together with cisplatin.
1. Name Of The Medicinal Product
Gyno-Pevaryl™ Cream.
2. Qualitative And Quantitative Composition
Each 100 g of cream contains 1 g econazole nitrate Ph.Eur. (1% w/w).
3. Pharmaceutical Form
Vaginal Cream.
4. Clinical Particulars
4.1 Therapeutic Indications
For the treatment of mycotic vulvovaginitis and mycotic balanitis.
4.2 Posology And Method Of Administration
Route of Administration
For vaginal/penile administration.
Females: One applicator full (approximately 5 g) intravaginally once daily at night for not less than 14 days. The cream should also be applied to the vulva. The full 14 days treatment should be carried out even if the symptoms of vaginal itching or discharge have disappeared.
Males: Apply the cream to the penis, including under the foreskin, once daily for not less than 14 days.
The sexual partner should also be treated.
4.3 Contraindications
Hypersensitivity to any imidazole preparation, other vaginal antifungal products or to any of the ingredients of Gyno-Pevaryl cream.
4.4 Special Warnings And Precautions For Use
Not for ophthalmic or oral use.
Hypersensitivity has rarely been recorded; if it should occur administration should be discontinued.
Contact between contraceptive diaphragms or condoms and this product must be avoided since the rubber may be damaged by the preparation.
Patients using spermicidal contraceptives should consult their physician since any local vaginal treatment may inactivate the spermicidal contraceptive.
Gyno-Pevaryl Cream should not be used in conjunction with ot
1. Name Of The Medicinal Product
Glycerin, Lemon and Honey with Glucose or
Honey, Lemon and Glycerine
2. Qualitative And Quantitative Composition
Each 5ml of solution contains:-
1.36g Glycerol BP
Excipients: Each 5ml contains Syrup (sucrose) 1.7g, Liquid Glucose 280.0mg
For full list of excipients see section 6.1
3. Pharmaceutical Form
Linctus
4. Clinical Particulars
4.1 Therapeutic Indications
A soothing preparation for relief of the symptoms of coughs and sore throats.
4.2 Posology And Method Of Administration
Oral.
Recommended doses
Adults: two 5ml spoonfuls.
Children over 1 year: one 5ml spoonful.
Dosage schedule
May be repeated every 4 hours if required.
The product may be taken for up to 5 days, following which, if symptoms persist, medical advice should be sought.
Shake the bottle.
4.3 Contraindications
Hypersensitivity to any of the ingredients.
4.4 Special Warnings And Precautions For Use
Keep all medicines out of the reach and sight of children.
Not suitable for children under 1 year.
Not suitable for use in diabetics.
If symptoms persist, consult your doctor
Patients with rare glucose-galactose malabsorption should not take this medicine
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
None known.
4.6 Pregnancy And Lactation
No adverse effects are c
1. Name Of The Medicinal Product
Glycerin BP or Value Health Glycerin BP
2. Qualitative And Quantitative Composition
|
Active Ingredient |
|
|
Glycerol Ph Eur |
100%v/v |
3. Pharmaceutical Form
Liquid
4. Clinical Particulars
4.1 Therapeutic Indications
For the symptomatic relief of coughs and soreness of the throat.
For the symptomatic relief of dry skin conditions.
4.2 Posology And Method Of Administration
For oral and topical administration.
Adults and Children over 12 years: 10ml
Children 5 to 12 years: 5ml
Children 1 - 5 years: 2.5ml
The dose should be mixed with a little water and sipped three or four times a day.
Elderly: There is no need for dosage reduction in the elderly.
For external application apply undiluted or mixed with a little water.
4.3 Contraindications
Hypersensitivity to glycerin.
4.4 Special Warnings And Precautions For Use
Glycerin should be administered with caution to diabetic patients and those at risk of dehydration.
Keep all medicines out of the reach of children.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
No clinically significant drug interactions known.
1. Name Of The Medicinal Product
Gaviscon Advance Mint Chewable Tablets.
2. Qualitative And Quantitative Composition
Each tablet contains sodium alginate 500 mg and potassium bicarbonate 100 mg.
For excipients, see Section 6.1.
3. Pharmaceutical Form
Chewable tablet.
An off-white to cream, circular, flat with bevelled edges tablet with the odour and flavour of peppermint. Each tablet is imprinted with a "Sword and Circle" on one side and "GA500" on the reverse.
4. Clinical Particulars
4.1 Therapeutic Indications
Treatment of symptoms resulting from the reflux of acid, bile and pepsin into the oesophagus such as acid regurgitation, heartburn, indigestion (occurring due to the reflux of stomach contents), for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux oesophagitis, including symptoms of laryngopharyngeal reflux such as hoarseness and other voice disorders, sore throats and cough. It can also be used to treat the symptoms of gastro-oesophageal reflux during concomitant treatment with or following withdrawal of acid suppressing therapy.
4.2 Posology And Method Of Administration
For oral administration, after being thoroughly chewed.
Adults and children 12 years and over: One to two tablets after meals and at bedtime.
Children under 12 years: Should be given only on medical advice.
Elderly: No dose modifications necessary for this age group.
4.3 Contraindications
This medicinal product is contraindicated in patients with known or suspected hypersensitivity to the active substances or to any of the excipients.
4.4 Special Warnings And Precautions For Use
1. Name Of The Medicinal Product
Galantamine 4 mg/ml oral solution
2. Qualitative And Quantitative Composition
1 ml oral solution contains 4 mg galantamine (as hydrobromide).
Excipients: 0.33 g Sorbitol/ml, 1.66 mg Methylparahydroxybenzoate/ml, 0.2 mg Propylparahydroxybenzoate/ml
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Oral solution.
Clear, colourless solution
4. Clinical Particulars
4.1 Therapeutic Indications
Galantamine is indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.
4.2 Posology And Method Of Administration
Adults/elderly
Administration
Galantamine oral solution should be administered twice a day, preferably with morning and evening meals. Ensure adequate fluid intake during treatment (See section 4.8).
Before start of treatment
The diagnosis of probable Alzheimer type of dementia should be adequately confirmed according to current clinical guidelines (see section 4.4).
Starting dose
The recommended starting dose is 8 mg/day (4 mg twice a day) for four weeks.
Maintenance dose
• The tolerance and dosing of galantamine should be reassessed on a regular basis, preferably within three months after start of treatment. Thereafter, the clinical benefit of galantamine and the patient's tolerance of treatment should be reassessed on a regular basis according to current clinical guidelines. Maintenance treatment can be continued for as long as therapeut
1. Name Of The Medicinal Product
Gabapentin 100mg capsules
2. Qualitative And Quantitative Composition
Each capsule contains 100mg of gabapentin
For excipients, see 6.1
3. Pharmaceutical Form
Capsules,hard
Size 3, white-white, hard gelatin capsules printed with C and GJ .
4. Clinical Particulars
4.1 Therapeutic Indications
Epilepsy
Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalisation in adults and children aged 6 years and above (see section 5.1).
Gabapentin is indicated as monotherapy in the treatment of partial seizures with and without secondary generalisation in adults and adolescents aged 12 years and above.
Treatment of peripheral neuropathic pain
Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults.
4.2 Posology And Method Of Administration
For oral use.
Gabapentin can be given with or without food and should be swallowed whole with sufficient fluid intake (e.g. a glass of water).
For all indications a titration scheme for the initiation of therapy is described in Table 1, which is recommended for adults and adolescents aged 12 years and above. Dosing instructions for children under 12 years of age are provided under a separate sub-heading later in this section.
|
Table 1 |
||
1. Name Of The Medicinal Product
GLYCERYL TRINITRATE TABLETS BP 600 micrograms
2. Qualitative And Quantitative Composition
Each tablet contains 600 micrograms Glyceryl Trinitrate BP.
3. Pharmaceutical Form
White uncoated tablets.
White, circular, biconvex uncoated tablets, impressed “C” on one face and the identifying letters “GS” on reverse.
4. Clinical Particulars
4.1 Therapeutic Indications
As a short-acting vasodilator in the:
1. Relief of angina pectoris
2. Prophylaxis of angina pectoris
3. Relief of acute spontaneous coronary artery spasm
4.2 Posology And Method Of Administration
Posology
1-2 tablets (0.6-1.2mg) should be placed under the tongue and allowed to dissolve slowly; this dose should be repeated as required. If pain persists after a total of 3 doses in 15minutes the patient should be advised to seek medical attention.
Dosage should be adjusted according to the response obtained by the individual patient and the severity of the anginal pain.
NB Tolerance may develop with daily use, but withdrawal for a week re-establishes the original sensitivity.
Method of Administration
For sublingual administration
4.3 Contraindications
Known hypersensitivity to nitrates and other ingredients in the tablets. Patients with rare hereditary problems of galactose intolerence, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Marked anaemia, raised intercranial pressure including that caused by head trauma, cerebral haemorrhage, closed angle glau
1. Name Of The Medicinal Product
Gentamicin Intrathecal 5mg/ml Solution for Injection.
2. Qualitative And Quantitative Composition
Each ampoule (1ml) contains Gentamicin Sulphate Ph Eur equivalent to 5mg Gentamicin base.
3. Pharmaceutical Form
Injection.
4. Clinical Particulars
4.1 Therapeutic Indications
Gentamicin is an aminoglycoside antibiotic with broad-spectrum bactericidal activity. It is usually active against most strains of the following organisms: Escherichia coli, Klebsiella spp., Proteus spp. (indole positive and indole negative), Pseudomonas aeruginosa, Staphylococci, Enterobacter spp., Citrobacter spp. and Providencia spp.
Gentamicin Intrathecal Injection is indicated as a supplement to systemic therapy in bacterial meningitis, ventriculitis and other bacterial infections of the central nervous system.
4.2 Posology And Method Of Administration
Bacterial meningitis and ventriculitis:
The starting dose of Gentamicin Intrathecal Injection for both children and adults is 1mg daily, intrathecally or intraventricularly, together with 1mg/kg every eight hours intramuscularly.
The MIC of the infecting organism in the C.S.F. should be assessed and, if necessary, the intrathecal/intraventricular dose increased to 5mg daily, whilst keeping the intramuscular dose at 1mg/kg eight-hourly.
Treatment should be continued for at least 7 days but longer if necessary.
Periodic serum and C.S.F. gentamicin assays should be carried out to ensure that adequate antibiotic levels are maintained and that serum and C.S.F. levels do not exceed 10mg/l.
Route of Administration
Intrathecal or intraventricular.
Gemeprost 1mg Pessary
gemeprost
Is this leaflet hard to see or read? Phone 01483 505515 for help
Read all of this leaflet carefully before you are given this medicine
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask you doctor or nurse.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or nurse.
In this leaflet:
- 1. What Gemeprost Pessary is and what it is used for.
- 2. Before you are given Gemeprost Pessary
- 3. How you are given Gemeprost Pessary
- 4. Possible side effects
- 5. How Gemeprost Pessary is stored
- 6. Further information
What Gemeprost Pessary is and what it is used for
Gemeprost Pessary contains a medicine called gemeprost. This belongs to a group of medicines called prostaglandins. It works by making the womb contract. Gemeprost is normally given to women in the following situations:
- To make the operation to terminate a pregnancy in the first three months easier.
- To terminate a pregnancy between the fourth and sixth month.
- To terminate a pregnancy between the fourth and sixth month, if the unborn baby (foetus) has already died.
Before you are given Gemeprost Pessary
Do not use Gemeprost Pessary if:
- You are allergic (hypersensitive) to gemeprost or any of the other ingredients of this medicine (See section 6: Further information). Signs of an allergic reaction include:
1. Name Of The Medicinal Product
Glycerin Suppositories BP 1g Infants' Size
2. Qualitative And Quantitative Composition
Glycerol BP 70% w/w.
3. Pharmaceutical Form
Suppositories.
4. Clinical Particulars
4.1 Therapeutic Indications
For the relief of occasional constipation.
4.2 Posology And Method Of Administration
|
Route of administration: |
Rectal. |
|
Dose: |
One suppository. |
|
Dosage schedule: |
As required. |
The suppository should be dipped in water before insertion.
The suppositories are defined as infants' size, therefore there is no adults' or children's use recommendation.
4.3 Contraindications
Contraindicated in patients with known hypersensitivity to glycerol.
4.4 Special Warnings And Precautions For Use
Keep all medicines away from children.
Not to be swallowed. Suppositories must not be taken by mouth. Consult your doctor before use.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
None known.
4.6 Pregnancy And Lactation
Not applicable.
4.7
1. Name Of The Medicinal Product
Gynoxin 2% vaginal cream
2. Qualitative And Quantitative Composition
Gynoxin contains 20 mg of the active ingredient fenticonazole nitrate in 1 g of cream.
For excipients, see 6.1
3. Pharmaceutical Form
Vaginal cream
White homogenous cream
4. Clinical Particulars
4.1 Therapeutic Indications
Treatment of vulvovaginal candidiasis.
4.2 Posology And Method Of Administration
Route of Administration:
Intravaginal
Adults:
One applicator full (about 5 g) is administered into the vagina by a re-usable applicator (morning and evening for three days).
Gynoxin is not greasy, does not soil and can easily be removed with water.
Children:
The use of Gynoxin in children is not recommended.
4.3 Contraindications
Ascertained hypersensitive to the product and to other imidazole derivatives.
4.4 Special Warnings And Precautions For Use
The product should not be used in conjunction with barrier contraceptives.
In the event of a hypersensitivity reaction or development of resistant organisms, treatment should be discontinued and the physician consulted.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
Not investigated. Since systemic absorption of fenticonazole after application is low, interactions with other drugs are unlikely.
4.6 Pregnancy And Lactation
Oral administration of fenticonazole in rats has been reported to produce prolonged gestation and embryotoxic effects after doses above 40mg/kg/day. Fenticonazole
Gyno-Pevaryl 1 vaginal pessary
Econazole nitrate
Gyno-Pevaryl is a registered trademark
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again
- If you have any further questions, ask your doctor or pharmacist
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours
- If you get side effects and they become serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist
In this leaflet
- 1. What Gyno-Pevaryl 1 is and what it is used for
- 2. Before you use Gyno-Pevaryl 1
- 3. How to use Gyno-Pevaryl 1
- 4. Possible side effects
- 5. How to store Gyno-Pevaryl 1
- 6. Further information
What Gyno-Pevaryl 1 is and what it is used for
The name of your medicine is Gyno-Pevaryl 1 vaginal pessary. It is called ‘Gyno-Pevaryl 1’ in this leaflet.
Gyno-Pevaryl 1 is a solid, bullet-shaped pessary (vaginal suppository). When inserted into the vagina it releases a medicine called econazole. This belongs to a group of medicines called ‘antifungals’.
Gyno-Pevaryl 1 is used for infections of the vagina and the skin around the vagina. The infections are caused by fungi and yeasts such as thrush (Candida).
Before you use Gyno-Pevaryl 1
Do not use Gyno-Pevaryl 1 if:
- You are allergic to anything in Gyno-Pevaryl 1 (listed in section
1. Name Of The Medicinal Product
GONAL-f 900 IU/1.5 ml (66 micrograms/1.5 ml) solution for injection in pre-filled pen.
2. Qualitative And Quantitative Composition
Each ml of the solution contains 600 IU of follitropin alfa*, (equivalent to 44 micrograms).
Each pre-filled multidose pen delivers 900 IU (equivalent to 66 micrograms) in 1.5 ml.
* recombinant human follicle stimulating hormone (r-hFSH) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Solution for injection in a pre-filled pen.
Clear colourless solution.
The pH of the solution is 6.7-7.3.
4. Clinical Particulars
4.1 Therapeutic Indications
In adult women
• Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomiphene citrate.
• Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.
• GONAL-f in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/l.
In adult men
• GONAL-f is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human Chorion
1. Name Of The Medicinal Product
Gabapentin 100 mg Capsules
2. Qualitative And Quantitative Composition
Each capsule, hard contains 100 mg of gabapentin.
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Capsule, hard
Hard gelatin capsule (size 3), with white opaque body and cap.
4. Clinical Particulars
4.1 Therapeutic Indications
Epilepsy
Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children aged 6 years and above (see section 5.1).
Gabapentin is indicated as monotherapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents aged 12 years and above.
Treatment of peripheral neuropathic pain
Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults.
4.2 Posology And Method Of Administration
For oral use.
Gabapentin can be given with or without food and should be swallowed whole with sufficient fluid-intake (e.g. a glass of water).
For all indications a titration scheme for the initiation of therapy is described in Table 1, which is recommended for adults and adolescents aged 12 years and above. Dosing instructions for children under 12 years of age are provided under a separate sub-heading later in this section.
|
Table 1 |
GHRH FERRING 50 micrograms
Somatorelin
Remember
Only a doctor can prescribe this medicine. It should never be given to anyone except the person it has been prescribed for. It may harm them even if they have the same symptoms.
Please read this information leaflet carefully before treatment with the medicine.
This leaflet does not contain the complete information, so if you have any questions or if there is anything you are unsure about, please ask your doctor or pharmacist.
Read all of this leaflet carefully before you are given this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor, nurse or pharmacist.
- If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist.
In this leaflet:
- 1. What GHRH is and what it is used for
- 2. Before GHRH is given to you
- 3. How GHRH is given to you
- 4. Possible side effects
- 5. How to store GHRH
- 6. Further information
What GHRH is and what it is used for
The full name of your medicine is GHRH Ferring. It is called GHRH in this leaflet. GHRH contains a medicine called somatorelin acetate. It is a man-made form of the natural hormone somatorelin.
- Somatorelin is made by a part of the brain called the hypothalamus.
- When it is released, it causes the pituitary gland (just underneath the brain) to release growth hormone.
GHRH is used when your doctor thinks that you may not have enough
Glyceryl Trinitrate tablets
500micrograms and 600micrograms
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
Index
- 1 What Glyceryl Trinitrate tablets are and what they are used for
- 2 Before you take
- 3 How to take
- 4 Possible side effects
- 5 How to store
- 6 Further information
What Glyceryl Trinitrate tablets are and what they are used for
Glyceryl Trinitrate belongs to a group of medicines called nitrate vasodilators. These medicines work by relaxing the blood vessels of the heart. This reduces the strain on the heart by making it easier to pump blood.
Glyceryl Trinitrate tablets BP may be used to:
- prevent or stop chest pain caused by angina pectoris
- stop spasms in the blood vessels of the heart.
Before you take
Do not take Glyceryl Trinitrate tablets and tell your doctor if you:
- are allergic (hypersensitive) to glyceryl